BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4414303)

  • 21. [Etiopathogenetic implications of viral infections during a course of multiple sclerosis: study of cellular immunity against measles and parotitis virus].
    Smeraldi E; Bottinelli S
    Acta Neurol (Napoli); 1973; 28(3):262-7. PubMed ID: 4732486
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiple sclerosis (second of two parts).
    McFarlin DE; McFarland HF
    N Engl J Med; 1982 Nov; 307(20):1246-51. PubMed ID: 6290885
    [No Abstract]   [Full Text] [Related]  

  • 23. Antimeasles serum antibodies in multiple sclerosis patients as compared with their relatives and cose contacts.
    Cernescu C; Verdeş F; Sorodoc Y
    Virologie; 1978; 29(1):69-70. PubMed ID: 636312
    [No Abstract]   [Full Text] [Related]  

  • 24. [Multiple sclerosis: advances in its pathogenesis].
    Godoy J; Court J
    Rev Med Chil; 1982 Jun; 110(6):581-4. PubMed ID: 6761822
    [No Abstract]   [Full Text] [Related]  

  • 25. Measles antibody in serum of multiple sclerosis patients, their children, siblings and parents.
    Ammitzboll T; Clausen J; Fog T
    Acta Neurol Scand Suppl; 1972; 51():365. PubMed ID: 4514352
    [No Abstract]   [Full Text] [Related]  

  • 26. Nontransmissibility of measles virus from vaccinated dogs to seronegative monkeys.
    Delforge JL; Zygraich N
    Mod Vet Pract; 1980 Dec; 61(12):1017-9. PubMed ID: 7464777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of the incidence of measles in Karl-Marx-Stadt County with special reference to infants].
    Hajduk F; Weiss O; Starke G; Bigl S; Kluge D; Gericke E
    Z Gesamte Hyg; 1980; 26(10):762-4. PubMed ID: 7467502
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of antibodies in hyperergic measles encephalitis].
    Zwoździak W; Galas-Zgorzalewicz B
    Pediatr Pol; 1973 Jul; 48(7):847-51. PubMed ID: 4731035
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple sclerosis, antiviral antibodies.
    Woyciechowska JL; Dambrosia J; Tzan N; Madden DL
    Lancet; 1982 Dec; 2(8313):1461-2. PubMed ID: 6129533
    [No Abstract]   [Full Text] [Related]  

  • 30. Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis.
    Arnason BG; Fuller TC; Lehrich JR; Wray SH
    J Neurol Sci; 1974 Aug; 22(4):419-28. PubMed ID: 4847303
    [No Abstract]   [Full Text] [Related]  

  • 31. [Status of immunization against measles in the pediatric population of the province of Ferrara].
    Bezzi TM; Soriani S; Trombini R; Scorrano M
    Minerva Pediatr; 1980 Apr; 32(8):581. PubMed ID: 7393191
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial: Virus markers in multiple sclerosis.
    Hirsch MS
    N Engl J Med; 1976 Jun; 294(26):1457-8. PubMed ID: 1272277
    [No Abstract]   [Full Text] [Related]  

  • 33. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.
    Willis MF; Warburton MF
    Med J Aust; 1974 May; 1(20):789-93. PubMed ID: 4853112
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of capillary blood specimens for testing measles HI antibody.
    Biberi-Moroeanu S; Tiţeica M
    Arch Roum Pathol Exp Microbiol; 1983; 42(4):317-9. PubMed ID: 6678574
    [No Abstract]   [Full Text] [Related]  

  • 35. On some therapeutical attempts with specific measles immunoglobulin in multiple sclerosis.
    Cajal N; Drăgănescu N; Cepleanu M; Cernescu C; Girjabu E; Sorodoc Y
    Rev Roum Virol (1972); 1973; 10(1):81-4. PubMed ID: 4709857
    [No Abstract]   [Full Text] [Related]  

  • 36. Serological responses of multiple-sclerosis patients and controls to a virus isolated from a multiple-sclerosis case.
    Nemo GJ; Brody JA; Waters DJ
    Lancet; 1974 Nov; 2(7888):1044-6. PubMed ID: 4138582
    [No Abstract]   [Full Text] [Related]  

  • 37. Optimum age for measles immunisation: study of pre- and post-immunization level of HI antibody titres.
    Bhatnagar SK; Mohan M; Kumar P; Balaya S; Prabhakar AK; Bhargava SK
    Indian Pediatr; 1981 Sep; 18(9):625-9. PubMed ID: 6797943
    [No Abstract]   [Full Text] [Related]  

  • 38. [Mechanisms of virus-induced and "allergic" demyelinations and their importance for the pathogenesis of multiple sclerosis. 2. The hosts reaction to virus-induced changes in the CNS].
    Simon J
    Immun Infekt; 1979 Nov; 7(5):151-6. PubMed ID: 396222
    [No Abstract]   [Full Text] [Related]  

  • 39. Demonstration of measles virus antibody in multiple sclerosis patients by menas of the photometric ACU method.
    Drescher J
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:117-20. PubMed ID: 5373023
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunological aspects of multiple sclerosis.
    Ammitzboll T; Clausen J; Fog T
    Acta Neurol Scand Suppl; 1977; 63():99-111. PubMed ID: 265672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.